ES2093138T3 - El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular. - Google Patents

El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular.

Info

Publication number
ES2093138T3
ES2093138T3 ES92108250T ES92108250T ES2093138T3 ES 2093138 T3 ES2093138 T3 ES 2093138T3 ES 92108250 T ES92108250 T ES 92108250T ES 92108250 T ES92108250 T ES 92108250T ES 2093138 T3 ES2093138 T3 ES 2093138T3
Authority
ES
Spain
Prior art keywords
methyl
oxohexil
xantina
propil
vascular surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92108250T
Other languages
English (en)
Inventor
Viera Dr Danielisova
Ralf Dr Kolvenbach
Hans-Peter Prof Dr Schubert
John Dr Grome
Ernst Jurgen Dr Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2093138T3 publication Critical patent/ES2093138T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA APLICACION DE 1 ROPIL OMPUESTO PARA LA PRODUCCION DE MEDICAMENTOS PARA LA PROFILAXIS Y TRATAMIENTO DE DAÑOS NERVIOSOS TRAS INTERRUPCION DE LA CIRCULACION SANGUINEA.
ES92108250T 1991-05-23 1992-05-15 El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular. Expired - Lifetime ES2093138T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116799 1991-05-23

Publications (1)

Publication Number Publication Date
ES2093138T3 true ES2093138T3 (es) 1996-12-16

Family

ID=6432229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92108250T Expired - Lifetime ES2093138T3 (es) 1991-05-23 1992-05-15 El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular.

Country Status (16)

Country Link
US (1) US5475002A (es)
EP (1) EP0514789B1 (es)
JP (1) JP3193767B2 (es)
KR (1) KR100219011B1 (es)
AT (1) ATE142498T1 (es)
AU (1) AU651205B2 (es)
CA (1) CA2069202C (es)
DE (1) DE59207086D1 (es)
DK (1) DK0514789T3 (es)
ES (1) ES2093138T3 (es)
GR (1) GR3021039T3 (es)
HU (1) HU207798B (es)
IE (1) IE75890B1 (es)
IL (1) IL101953A (es)
TW (1) TW207497B (es)
ZA (1) ZA923747B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214938A3 (en) * 1991-05-24 2003-08-06 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
WO2000071128A1 (en) * 1999-04-06 2000-11-30 Trustees Of Dartmouth College Compositions and method for decreasing neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤

Also Published As

Publication number Publication date
JPH05139976A (ja) 1993-06-08
DE59207086D1 (de) 1996-10-17
ZA923747B (en) 1992-12-30
TW207497B (es) 1993-06-11
HUT61469A (en) 1993-01-28
CA2069202A1 (en) 1992-11-24
CA2069202C (en) 2003-12-09
ATE142498T1 (de) 1996-09-15
EP0514789A1 (de) 1992-11-25
AU1706392A (en) 1992-11-26
US5475002A (en) 1995-12-12
HU207798B (en) 1993-06-28
IE75890B1 (en) 1997-09-24
IL101953A0 (en) 1992-12-30
KR100219011B1 (ko) 1999-09-01
GR3021039T3 (en) 1996-12-31
EP0514789B1 (de) 1996-09-11
DK0514789T3 (es) 1997-02-17
AU651205B2 (en) 1994-07-14
IE921658A1 (en) 1992-12-02
IL101953A (en) 1995-07-31
HU9201695D0 (en) 1992-08-28
JP3193767B2 (ja) 2001-07-30

Similar Documents

Publication Publication Date Title
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
ES2066278T3 (es) Derivados del alcoxipirimidina contra la migraña.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
CA2148194A1 (en) Cyclopeptides of the formula i
NO882853D0 (no) Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocytfunkjon.
NO170332C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(4-hydroksy-3,5-di-tert.-butyl-benzoyl)-homopiperaziner
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ES2093138T3 (es) El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular.
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
ES2099736T3 (es) Utilizacion de derivados de la 15-deshidroxi-16-oxoprostaglandina en el tratamiento de las alergias.
FI950010A0 (fi) Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi
PT711163E (pt) Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
SE8702227D0 (sv) New use
ECSP982757A (es) Tienopirimidinas
ECSP992935A (es) Tienopirimidinas
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
IT231604Y1 (it) Letto per la terapia di fluidizzazione in particolare per il decupito o la cura di ustioni

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 514789

Country of ref document: ES